Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma (vol 38, 2201408, 2023)

被引：0
|
作者：
Peng, Xiaopeng
Yu, Ziwen
Surineni, Goverdhan
Deng, Bulian
Zhang, Meizhu
Li, Chuan
Sun, Zhiqiang
Pan, Wanyi
Liu, Yao
Liu, Shenglan
Yu, Bin
Chen, Jianjun
机构：
来源：
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY | 2024年 / 39卷 / 01期
关键词：
D O I：
10.1080/14756366.2024.2374156
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页数：1
相关论文
共 10 条
  • [1] Discovery of novel benzohydroxamate-based histone deacetylase 6 (HDAC6) inhibitors with the ability to potentiate anti-PD-L1 immunotherapy in melanoma
    Peng, Xiaopeng
    Yu, Ziwen
    Surineni, Goverdhan
    Deng, Bulian
    Zhang, Meizhu
    Li, Chuan
    Sun, Zhiqiang
    Pan, Wanyi
    Liu, Yao
    Liu, Shenglan
    Yu, Bin
    Chen, Jianjun
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2023, 38 (01)
  • [2] Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma
    Peng, Xiaopeng
    Li, Ling
    Chen, Jingxuan
    Ren, Yichang
    Liu, Jin
    Yu, Ziwen
    Cao, Hao
    Chen, Jianjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (03) : 2434 - 2457
  • [3] Role of Fluorination in the Histone Deacetylase 6 (HDAC6) Selectivity of Benzohydroxamate-Based Inhibitors
    Sandrone, Giovanni
    Cukier, Cyprian D.
    Zrubek, Karol
    Marchini, Mattia
    Vergani, Barbara
    Caprini, Gianluca
    Fossati, Gianluca
    Steinkuhler, Christian
    Stevenazzi, Andrea
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (11): : 1810 - 1817
  • [4] Discovery of Novel Histone Deacetylase 6 (HDAC6) Inhibitors with Enhanced Antitumor Immunity of Anti-PD-L1 Immunotherapy in Melanoma( vol 65, pg 2434, 2022)
    Peng, Xiaopeng
    Li, Ling
    Chen, Jingxuan
    Ren, Yichang
    Liu, Jin
    Yu, Ziwen
    Cao, Hao
    Chen, Jianjun
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (21) : 19926 - 19927
  • [5] Novel Benzohydroxamate-Based Potent and Selective Histone Deacetylase 6 (HDAC6) Inhibitors Bearing a Pentaheterocyclic Scaffold: Design, Synthesis, and Biological Evaluation
    Vergani, Barbara
    Sandrone, Giovanni
    Marchini, Mattia
    Ripamonti, Chiara
    Cellupica, Edoardo
    Galbiati, Elisabetta
    Caprini, Gianluca
    Pavich, Gianfranco
    Porro, Giulia
    Rocchio, Ilaria
    Lattanzio, Maria
    Pezzuto, Marcello
    Skorupska, Malgorzata
    Cordella, Paola
    Pagani, Paolo
    Pozzi, Pietro
    Pomarico, Roberta
    Modena, Daniela
    Leoni, Flavio
    Perego, Raffaella
    Fossati, Gianluca
    Steinkuhler, Christian
    Stevenazzi, Andrea
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (23) : 10711 - 10739
  • [6] Histone deacetylase 6 (HDAC6) as a regulator of PD-L1 expression through STAT3 modulation in melanoma
    Lienlaf, Maritza
    Perez-Villarroel, Patricio
    Lee, Calvin
    Cheng, Fengdong
    Canales, Jorge
    Knox, Tessa
    Marante, Danay
    Sarnaik, Amod
    Horna, Pedro
    Seto, Ed.
    Smalley, Keiran
    Weber, Jeffrey S.
    Sotomayor, Eduardo M.
    Villagra, Alejandro
    CANCER RESEARCH, 2014, 74 (19)
  • [7] Discovery of Novel and Highly Potent Dual PD-L1/Histone Deacetylase 6 Inhibitors with Favorable Pharmacokinetics for Cancer Immunotherapy
    Hu, Zhihao
    Li, Shuqing
    He, Haiqi
    Pan, Wanyi
    Liu, Ting
    Liang, Hailiu
    Xu, Congcong
    Lu, Benyan
    Tao, Chengpeng
    Qi, Zetao
    Cheng, Binbin
    Hu, Ying
    Jiang, Feng
    Chen, Jianjun
    Peng, Xiaopeng
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (05) : 5426 - 5454
  • [8] Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
    A Ray
    D S Das
    Y Song
    T Hideshima
    Y-T Tai
    D Chauhan
    K C Anderson
    Leukemia, 2018, 32 : 843 - 846
  • [9] Combination of a novel HDAC6 inhibitor ACY-241 and anti-PD-L1 antibody enhances anti-tumor immunity and cytotoxicity in multiple myeloma
    Ray, A.
    Das, D. S.
    Song, Y.
    Hideshima, T.
    Tai, Y-T
    Chauhan, D.
    Anderson, K. C.
    LEUKEMIA, 2018, 32 (03) : 843 - 846
  • [10] Discovery of novel thiophene[3,2-d]pyrimidine-based d ]pyrimidine-based tubulin inhibitors with enhanced antitumor efficacy for combined use with anti-pd-l1 immunotherapy in melanoma
    Xu, Chenglong
    Wu, Chengyong
    Li, Ling
    Zhao, Huiting
    Liu, Jin
    Peng, Xiaopeng
    Wang, Yuxi
    Chen, Jianjun
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 277
1